| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13G | Open Document | Open Filing | Dec 2, 2025 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | Aug 20, 2025 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | Aug 15, 2025 | |||
| SCHEDULE 13G | Open Document | Open Filing | Jun 30, 2025 | |||
| SCHEDULE 13D/A | Open Document | Open Filing | May 30, 2025 | |||
| SCHEDULE 13D | Open Document | Open Filing | May 22, 2025 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | May 20, 2025 | |||
| 4 | Open Document | Open Filing | 4 | May 19, 2025 | May 15, 2025 | 001-40315 |
| SCHEDULE 13G/A | Open Document | Open Filing | Feb 14, 2025 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | Feb 14, 2025 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | Nov 14, 2024 | |||
| SCHEDULE 13G/A | Open Document | Open Filing | Nov 14, 2024 | |||
| 3 | Open Document | Open Filing | 3 | Oct 9, 2024 | Oct 4, 2024 | 001-40315 |
| SC 13G | Open Document | Open Filing | SC 13G | Oct 9, 2024 | ||
| SCHEDULE 13G | Open Document | Open Filing | Aug 13, 2024 | |||
| SC 13D | Open Document | Open Filing | Q32 BIO INC. | Apr 4, 2024 | ||
| SC 13G | Open Document | Open Filing | Feb 14, 2024 | |||
| SC 13G/A | Open Document | Open Filing | OPTINOSE, INC. | Feb 13, 2024 | ||
| SC 13G/A | Open Document | Open Filing | CYCLACEL PHARMACEUTICALS, INC. | Feb 7, 2024 | ||
| SC 13G/A | Open Document | Open Filing | CARDIFF ONCOLOGY, INC. | Feb 6, 2024 | ||
| SC 13G/A | Open Document | Open Filing | Y-MABS THERAPEUTICS, INC. | Feb 6, 2024 | ||
| SC 13G/A | Open Document | Open Filing | BIOATLA, INC. | Feb 6, 2024 | ||
| SC 13G/A | Open Document | Open Filing | PUMA BIOTECHNOLOGY, INC. | Feb 6, 2024 | ||
| SC 13G | Open Document | Open Filing | PUMA BIOTECHNOLOGY, INC. | Sep 1, 2023 | ||
| SC 13G | Open Document | Open Filing | BIOATLA, INC. | Apr 27, 2023 | ||
| SC 13G | Open Document | Open Filing | Y-MABS THERAPEUTICS, INC. | Apr 3, 2023 | ||
| SC 13G/A | Open Document | Open Filing | CYCLACEL PHARMACEUTICALS, INC. | Jan 26, 2023 | ||
| SC 13G | Open Document | Open Filing | CARDIFF ONCOLOGY, INC. | Jan 26, 2023 | ||
| SC 13D/A | Open Document | Open Filing | CARDIFF ONCOLOGY, INC. | Jan 26, 2023 | ||
| SC 13G | Open Document | Open Filing | OPTINOSE, INC. | Dec 5, 2022 | ||
| SC 13G | Open Document | Open Filing | SC 13G | Feb 12, 2021 | ||
| SC 13D | Open Document | Open Filing | SC 13D | Jul 2, 2020 | ||
| SC 13G | Open Document | Open Filing | SC 13G | Jun 4, 2020 | ||
| D/A | Open Document | Open Filing | Mar 27, 2020 | 021-333917 | ||
| D | Open Document | Open Filing | Mar 1, 2019 | 021-333917 |